OBSEGONE Trademark

Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; diet tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patients.